Genotyping Market Overview and Growth by 2031
Genotyping Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Instruments, Reagents and Kits, Bioinformatics, and Genotyping Services), Technology [Microarray, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction (PCR), Matrix-Assisted Laser Desorption/MALDI-TOF, and Other Technologies], Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Other Applications), End User (Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, and Other End Users), and Geography (North America, Europe, Asia Pacific, and Middle East & Africa)
- Status : Published
- Report Code : TIPHE100001166
- Category : Life Sciences
- No. of Pages : 250
- Available Report Formats :
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product and Service, Technology, Application, End-User and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The increasing popularity of personalized medicine would persist as a prime trend in the market in the coming years.
North America dominated the market in 2023.
The use in the diagnosis of genetic and rare diseases, and technological advancements and rising R&D investments in the biotechnology and pharmaceutical industry are among the most significant factors fueling the market growth.
The genotyping market value is expected to reach US$ 154.35 billion by 2031.
The market is expected to register a CAGR of 22.5% during 2023–2031.
F. Hoffmann-La Roche Ltd, QIAGEN NV, Merck KGaA, Eurofins Genomics, Thermo Fisher Scientific Inc, BioTek Instruments Inc, Xcelris, Trimgen Corporation, Illumina Inc, Danaher Corp, Bio-Rad Laboratories, HE Healthcare Technologies, Standard Biotools Inc, Laboratory Corp of America Holdings, Beckmann Coulter, BGI, Takara Bio, and Diasorin Spa are among the key players in the market.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Genotyping Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Global Market Share Analysis
4.3.1 Global Market Share (%) of Leading Players for NGS Library Preparation
4.3.2 Global Market Share (%) of Leading Player for Genotyping
4.3.3 Global Market Share (%) of Leading Player for Gene Expression
5. Genotyping Market – Key Market Dynamics
5.1 Genotyping Market – Key Market Dynamics
5.2 Market Drivers:
5.2.1 Use in Diagnosis of Genetic and Rare Diseases
5.2.2 Technological Advancements and Rising R&D Investments in Biotechnology and Pharmaceutical Industry
5.3 Market Restraints
5.3.1 High Cost of Equipment and Shortage of Skilled Professionals
5.4 Market Opportunities
5.4.1 Expanding Range of Applications
5.5 Future Trends
5.5.1 Increasing Popularity of Personalized Medicine
5.6 Impact of Drivers and Restraints:
6. Genotyping Market – Global Market Analysis
6.1 Genotyping Market Revenue (US$ Million), 2021–2031
7. Genotyping Market Analysis – by Product Type
7.1 Instruments
7.1.1 Overview
7.1.2 Instruments: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Reagents and Kits
7.2.1 Overview
7.2.2 Reagents and Kits: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Bioinformatics
7.3.1 Overview
7.3.2 Bioinformatics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Genotyping Services
7.4.1 Overview
7.4.2 Genotyping Services: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8. Genotyping Market Analysis – by Technology
8.1 Microarray
8.1.1 Overview
8.1.2 Microarray: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Capillary Electrophoresis
8.2.1 Overview
8.2.2 Capillary Electrophoresis: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Sequencing
8.3.1 Overview
8.3.2 Sequencing: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Polymerase Chain Reaction (PCR)
8.4.1 Overview
8.4.2 Polymerase Chain Reaction (PCR): Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8.5 Matrix-Assisted Laser Desorption / MALDI-TOF
8.5.1 Overview
8.5.2 Matrix-Assisted Laser Desorption / MALDI-TOF: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8.6 Other Technologies
8.6.1 Overview
8.6.2 Other Technologies: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
9. Genotyping Market Analysis – by Application
9.1 Pharmacogenomics
9.1.1 Overview
9.1.2 Pharmacogenomics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Diagnostics and Personalized Medicine
9.2.1 Overview
9.2.2 Diagnostics and Personalized Medicine: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Animal Genetics
9.3.1 Overview
9.3.2 Animal Genetics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Agricultural Biotechnology
9.4.1 Overview
9.4.2 Agricultural Biotechnology: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
9.5 Other Applications
9.5.1 Overview
9.5.2 Other Applications: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
10. Genotyping Market Analysis – by End-user
10.1 Pharmaceutical and Biopharmaceutical Companies
10.1.1 Overview
10.1.2 Pharmaceutical and Biopharmaceutical Companies: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
10.2 Diagnostic and Research Laboratories
10.2.1 Overview
10.2.2 Diagnostic and Research Laboratories: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Academic Institutes
10.3.1 Overview
10.3.2 Academic Institutes: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
10.4 Other End Users
10.4.1 Overview
10.4.2 Other End Users: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11. Genotyping Market – Geographical Analysis
11.1 Overview
11.2 North America
11.2.1 North America Genotyping Market Overview
11.2.2 North America: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.2.2.1 North America: Genotyping Market – Revenue and Forecast Analysis – by Product Type
11.2.2.2 North America: Genotyping Market – Revenue and Forecast Analysis – by Technology
11.2.2.3 North America: Genotyping Market – Revenue and Forecast Analysis – by Application
11.2.2.4 North America: Genotyping Market – Revenue and Forecast Analysis – by End-user
11.2.3 North America: Genotyping Market – Revenue and Forecast Analysis – by Country
11.2.3.1 United States: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.2.3.1.1 United States: Genotyping Market Breakdown, by Product Type
11.2.3.1.2 United States: Genotyping Market Breakdown, by Technology
11.2.3.1.3 United States: Genotyping Market Breakdown, by Application
11.2.3.1.4 United States: Genotyping Market Breakdown, by End-user
11.2.3.2 Canada: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.2.3.2.1 Canada: Genotyping Market Breakdown, by Product Type
11.2.3.2.2 Canada: Genotyping Market Breakdown, by Technology
11.2.3.2.3 Canada: Genotyping Market Breakdown, by Application
11.2.3.2.4 Canada: Genotyping Market Breakdown, by End-user
11.2.3.3 Mexico: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.2.3.3.1 Mexico: Genotyping Market Breakdown, by Product Type
11.2.3.3.2 Mexico: Genotyping Market Breakdown, by Technology
11.2.3.3.3 Mexico: Genotyping Market Breakdown, by Application
11.2.3.3.4 Mexico: Genotyping Market Breakdown, by End-user
11.3 Europe
11.3.1 Europe Genotyping Market Overview
11.3.2 Europe: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.3.2.1 Europe: Genotyping Market – Revenue and Forecast Analysis – by Product Type
11.3.2.2 Europe: Genotyping Market – Revenue and Forecast Analysis – by Technology
11.3.2.3 Europe: Genotyping Market – Revenue and Forecast Analysis – by Application
11.3.2.4 Europe: Genotyping Market – Revenue and Forecast Analysis – by End-user
11.3.3 Europe: Genotyping Market – Revenue and Forecast Analysis – by Country
11.3.3.1 United Kingdom: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3.1.1 United Kingdom: Genotyping Market Breakdown, by Product Type
11.3.3.1.2 United Kingdom: Genotyping Market Breakdown, by Technology
11.3.3.1.3 United Kingdom: Genotyping Market Breakdown, by Application
11.3.3.1.4 United Kingdom: Genotyping Market Breakdown, by End-user
11.3.3.2 Germany: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3.2.1 Germany: Genotyping Market Breakdown, by Product Type
11.3.3.2.2 Germany: Genotyping Market Breakdown, by Technology
11.3.3.2.3 Germany: Genotyping Market Breakdown, by Application
11.3.3.2.4 Germany: Genotyping Market Breakdown, by End-user
11.3.3.3 France: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3.3.1 France: Genotyping Market Breakdown, by Product Type
11.3.3.3.2 France: Genotyping Market Breakdown, by Technology
11.3.3.3.3 France: Genotyping Market Breakdown, by Application
11.3.3.3.4 France: Genotyping Market Breakdown, by End-user
11.3.3.4 Spain: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3.4.1 Spain: Genotyping Market Breakdown, by Product Type
11.3.3.4.2 Spain: Genotyping Market Breakdown, by Technology
11.3.3.4.3 Spain: Genotyping Market Breakdown, by Application
11.3.3.4.4 Spain: Genotyping Market Breakdown, by End-user
11.3.3.5 Italy: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3.5.1 Italy: Genotyping Market Breakdown, by Product Type
11.3.3.5.2 Italy: Genotyping Market Breakdown, by Technology
11.3.3.5.3 Italy: Genotyping Market Breakdown, by Application
11.3.3.5.4 Italy: Genotyping Market Breakdown, by End-user
11.3.3.6 Rest of Europe: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3.6.1 Rest of Europe: Genotyping Market Breakdown, by Product Type
11.3.3.6.2 Rest of Europe: Genotyping Market Breakdown, by Technology
11.3.3.6.3 Rest of Europe: Genotyping Market Breakdown, by Application
11.3.3.6.4 Rest of Europe: Genotyping Market Breakdown, by End-user
11.4 Asia Pacific
11.4.1 Asia Pacific Genotyping Market Overview
11.4.2 Asia Pacific: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.4.2.1 Asia Pacific: Genotyping Market – Revenue and Forecast Analysis – by Product Type
11.4.2.2 Asia Pacific: Genotyping Market – Revenue and Forecast Analysis – by Technology
11.4.2.3 Asia Pacific: Genotyping Market – Revenue and Forecast Analysis – by Application
11.4.2.4 Asia Pacific: Genotyping Market – Revenue and Forecast Analysis – by End-user
11.4.3 Asia Pacific: Genotyping Market – Revenue and Forecast Analysis – by Country
11.4.3.1 China: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.4.3.1.1 China: Genotyping Market Breakdown, by Product Type
11.4.3.1.2 China: Genotyping Market Breakdown, by Technology
11.4.3.1.3 China: Genotyping Market Breakdown, by Application
11.4.3.1.4 China: Genotyping Market Breakdown, by End-user
11.4.3.2 Japan: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.4.3.2.1 Japan: Genotyping Market Breakdown, by Product Type
11.4.3.2.2 Japan: Genotyping Market Breakdown, by Technology
11.4.3.2.3 Japan: Genotyping Market Breakdown, by Application
11.4.3.2.4 Japan: Genotyping Market Breakdown, by End-user
11.4.3.3 India: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.4.3.3.1 India: Genotyping Market Breakdown, by Product Type
11.4.3.3.2 India: Genotyping Market Breakdown, by Technology
11.4.3.3.3 India: Genotyping Market Breakdown, by Application
11.4.3.3.4 India: Genotyping Market Breakdown, by End-user
11.4.3.4 Australia: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.4.3.4.1 Australia: Genotyping Market Breakdown, by Product Type
11.4.3.4.2 Australia: Genotyping Market Breakdown, by Technology
11.4.3.4.3 Australia: Genotyping Market Breakdown, by Application
11.4.3.4.4 Australia: Genotyping Market Breakdown, by End-user
11.4.3.5 South Korea: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.4.3.5.1 South Korea: Genotyping Market Breakdown, by Product Type
11.4.3.5.2 South Korea: Genotyping Market Breakdown, by Technology
11.4.3.5.3 South Korea: Genotyping Market Breakdown, by Application
11.4.3.5.4 South Korea: Genotyping Market Breakdown, by End-user
11.4.3.6 Rest of APAC: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.4.3.6.1 Rest of APAC: Genotyping Market Breakdown, by Product Type
11.4.3.6.2 Rest of APAC: Genotyping Market Breakdown, by Technology
11.4.3.6.3 Rest of APAC: Genotyping Market Breakdown, by Application
11.4.3.6.4 Rest of APAC: Genotyping Market Breakdown, by End-user
11.5 Middle East and Africa
11.5.1 Middle East and Africa Genotyping Market Overview
11.5.2 Middle East and Africa: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.5.2.1 Middle East and Africa: Genotyping Market – Revenue and Forecast Analysis – by Product Type
11.5.2.2 Middle East and Africa: Genotyping Market – Revenue and Forecast Analysis – by Technology
11.5.2.3 Middle East and Africa: Genotyping Market – Revenue and Forecast Analysis – by Application
11.5.2.4 Middle East and Africa: Genotyping Market – Revenue and Forecast Analysis – by End-user
11.5.3 Middle East and Africa: Genotyping Market – Revenue and Forecast Analysis – by Country
11.5.3.1 Saudi Arabia: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.5.3.1.1 Saudi Arabia: Genotyping Market Breakdown, by Product Type
11.5.3.1.2 Saudi Arabia: Genotyping Market Breakdown, by Technology
11.5.3.1.3 Saudi Arabia: Genotyping Market Breakdown, by Application
11.5.3.1.4 Saudi Arabia: Genotyping Market Breakdown, by End-user
11.5.3.2 South Africa: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.5.3.2.1 South Africa: Genotyping Market Breakdown, by Product Type
11.5.3.2.2 South Africa: Genotyping Market Breakdown, by Technology
11.5.3.2.3 South Africa: Genotyping Market Breakdown, by Application
11.5.3.2.4 South Africa: Genotyping Market Breakdown, by End-user
11.5.3.3 United Arab Emirates: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.5.3.3.1 United Arab Emirates: Genotyping Market Breakdown, by Product Type
11.5.3.3.2 United Arab Emirates: Genotyping Market Breakdown, by Technology
11.5.3.3.3 United Arab Emirates: Genotyping Market Breakdown, by Application
11.5.3.3.4 United Arab Emirates: Genotyping Market Breakdown, by End-user
11.5.3.4 Rest of Middle East and Africa: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.5.3.4.1 Rest of Middle East and Africa: Genotyping Market Breakdown, by Product Type
11.5.3.4.2 Rest of Middle East and Africa: Genotyping Market Breakdown, by Technology
11.5.3.4.3 Rest of Middle East and Africa: Genotyping Market Breakdown, by Application
11.5.3.4.4 Rest of Middle East and Africa: Genotyping Market Breakdown, by End-user
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in Genotyping Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Hoffmann-La Roche Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 QIAGEN NV
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Merck KGaA
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 EUROFINS GENOMICS
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Thermo Fisher Scientific Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 BioTek Instruments, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 XCELRIS GENOMICS
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 TRIMGEN CORPORATION
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Illumina Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Danaher Corp
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Bio-Rad Laboratories Inc
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 GE HealthCare Technologies Inc
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 Standard BioTools Inc
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 Laboratory Corp of America Holdings
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Beckman Coulter Inc
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 BGI
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments
13.17 Takara Bio Inc
13.17.1 Key Facts
13.17.2 Business Description
13.17.3 Products and Services
13.17.4 Financial Overview
13.17.5 SWOT Analysis
13.17.6 Key Developments
13.18 DiaSorin SpA
13.18.1 Key Facts
13.18.2 Business Description
13.18.3 Products and Services
13.18.4 Financial Overview
13.18.5 SWOT Analysis
13.18.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms
List of Tables
Table 1. Genotyping Market Segmentation
Table 2. Genotyping Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 3. Genotyping Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 4. Genotyping Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 5. Genotyping Market – Revenue and Forecast to 2031 (US$ Million) – by End-user
Table 6. North America: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 7. North America: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 8. North America: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 9. North America: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 10. United States: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 11. United States: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 12. United States: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 13. United States: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 14. Canada: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 15. Canada: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 16. Canada: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 17. Canada: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 18. Mexico: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 19. Mexico: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 20. Mexico: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 21. Mexico: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 22. Europe: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 23. Europe: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 24. Europe: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 25. Europe: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 26. United Kingdom: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 27. United Kingdom: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 28. United Kingdom: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 29. United Kingdom: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 30. Germany: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 31. Germany: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 32. Germany: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 33. Germany: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 34. France: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 35. France: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 36. France: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 37. France: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 38. Spain: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 39. Spain: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 40. Spain: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 41. Spain: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 42. Italy: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 43. Italy: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 44. Italy: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 45. Italy: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 46. Rest of Europe: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 47. Rest of Europe: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 48. Rest of Europe: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 49. Rest of Europe: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 50. Asia Pacific: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 51. Asia Pacific: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 52. Asia Pacific: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 53. Asia Pacific: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 54. China: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 55. China: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 56. China: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 57. China: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 58. Japan: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 59. Japan: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 60. Japan: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 61. Japan: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 62. India: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 63. India: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 64. India: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 65. India: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 66. Australia: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 67. Australia: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 68. Australia: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 69. Australia: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 70. South Korea: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 71. South Korea: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 72. South Korea: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 73. South Korea: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 74. Rest of APAC: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 75. Rest of APAC: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 76. Rest of APAC: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 77. Rest of APAC: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 78. Middle East and Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 79. Middle East and Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 80. Middle East and Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 81. Middle East and Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 82. Saudi Arabia: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 83. Saudi Arabia: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 84. Saudi Arabia: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 85. Saudi Arabia: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 86. South Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 87. South Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 88. South Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 89. South Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 90. United Arab Emirates: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 91. United Arab Emirates: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 92. United Arab Emirates: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 93. United Arab Emirates: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 94. Rest of Middle East and Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 95. Rest of Middle East and Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 96. Rest of Middle East and Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 97. Rest of Middle East and Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 98. Recent Organic Growth Strategies in Genotyping Market
Table 99. Recent Inorganic Growth Strategies in the Genotyping Market
Table 100. Glossary of Terms, Genotyping Market
List of Figures
Figure 1. Genotyping Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Genotyping Market Revenue (US$ Million), 2021–2031
Figure 5. Genotyping Market Share (%) – by Product Type (2023 and 2031)
Figure 6. Instruments: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Reagents and Kits: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Bioinformatics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Genotyping Services: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Genotyping Market Share (%) – by Technology (2023 and 2031)
Figure 11. Microarray: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Capillary Electrophoresis: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Sequencing: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Polymerase Chain Reaction (PCR): Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Matrix-Assisted Laser Desorption / MALDI-TOF: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Other Technologies: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Genotyping Market Share (%) – by Application (2023 and 2031)
Figure 18. Pharmacogenomics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Diagnostics and Personalized Medicine: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Animal Genetics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 21. Agricultural Biotechnology: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 22. Other Applications: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Genotyping Market Share (%) – by End-user (2023 and 2031)
Figure 24. Pharmaceutical and Biopharmaceutical Companies: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 25. Diagnostic and Research Laboratories: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 26. Academic Institutes: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 27. Other End Users: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 28. Genotyping Market Breakdown by Region, 2023 and 2031 (%)
Figure 29. North America: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 30. North America: Genotyping Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 31. United States: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 32. Canada: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 33. Mexico: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 34. Europe: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 35. Europe: Genotyping Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 36. United Kingdom: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 37. Germany: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 38. France: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 39. Spain: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 40. Italy: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 41. Rest of Europe: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 42. Asia Pacific: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 43. Asia Pacific: Genotyping Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 44. China: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 45. Japan: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 46. India: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 47. Australia: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 48. South Korea: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 49. Rest of APAC: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 50. Middle East and Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 51. Middle East and Africa: Genotyping Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 52. Saudi Arabia: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 53. South Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 54. United Arab Emirates: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 55. Rest of Middle East and Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 56. Growth Strategies in Genotyping Market
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For